Shares of Eli Lilly and Company closed at $1,254.77 on August 22, 2026, a gain of 0.67% over the prior 24-hour period. The move extended a notable stretch of gains for the pharmaceutical giant, whose stock has risen 6.28% over the past seven days.
The broader one-month picture reflects similar strength. Over the past 30 days, LLY shares have advanced 7.89%, adding to the company's already substantial market valuation.
Eli Lilly's market capitalization stood at $1,109.2 billion as of the close, keeping the company among the most valuable publicly traded corporations. The stock's performance across all three measured timeframes — daily, weekly, and monthly — remained positive as of the August 22 session.
